Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1976-11-12
1978-10-03
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
260559AT, 424 9, 250303, 422 61, A61K 2900, A61K 4300
Patent
active
041184688
ABSTRACT:
A diagnostic agent for the visualization of the kidneys is disclosed as well as a process for its manufacture. The new agent consists of pyrrolidinomethyl-tetracycline in a buffer solution, a tin(II) salt and technetium-99m in physiological sodium chloride solution.
REFERENCES:
patent: 3137627 (1964-06-01), Buckwalter et al.
patent: 3725295 (1973-04-01), Eckelman et al.
patent: 3740418 (1973-06-01), Rajamani et al.
patent: 3859429 (1975-01-01), Elias
patent: 3985768 (1976-10-01), Priestap et al.
Kasmarker Reinhard
Kloss Gerhard
Strecker Helmut
Hoechst Aktiengesellschaft
Nucker Christine M.
Padgett Benjamin R.
LandOfFree
Technetium-99m-labelled diagnostic agent for kidney scanning and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Technetium-99m-labelled diagnostic agent for kidney scanning and, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Technetium-99m-labelled diagnostic agent for kidney scanning and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1801955